Ahmad Alhuraiji Selected Research

Ahmad Alhuraiji Research Topics

4	Infections 05/2020 - 07/2016
4	Neoplasms (Cancer) 05/2020 - 01/2018
3	COVID-19 01/2021 - 01/2020
2	Multiple Myeloma 04/2024 - 01/2018
2	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 09/2022 - 01/2018
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 05/2020 - 01/2018
1	Hematologic Neoplasms (Hematological Malignancy) 10/2023
1	Sudden Infant Death (SID) 10/2023
1	Chylothorax 09/2022
1	Pleural Effusion (Pleural Effusions) 09/2022
1	Cytopenia 05/2020
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2018
1	Chromosome Aberrations (Chromosome Abnormalities) 01/2018
1	Graft vs Host Disease (Graft-Versus-Host Disease) 12/2016
1	Hepatitis C 11/2016
1	Liver Diseases (Liver Disease) 07/2016
1	Hepatitis 07/2016
1	Coinfection 07/2016
1	Hepatitis B 07/2016

2	Tyrosine Kinase InhibitorsIBA 09/2022 - 01/2018
1	Dasatinib (BMS 354825)FDA Link 09/2022
1	Dihydrotachysterol (AT 10)IBA 01/2021
1	Lenalidomide (CC 5013)FDA Link 01/2018
1	SteroidsIBA 12/2016
1	Glucose (Dextrose)FDA LinkGeneric 11/2016
1	Alanine Transaminase (SGPT)IBA 07/2016
1	RNA (Ribonucleic Acid)IBA 07/2016
1	Alanine (L-Alanine)FDA Link 07/2016

3	Therapeutics 05/2020 - 07/2016
2	Drug Therapy (Chemotherapy) 04/2024 - 05/2020
2	Hematopoietic Stem Cell Transplantation 10/2023 - 05/2020
1	Hand Hygiene 01/2020
1	Adjuvant Chemotherapy 01/2020
1	Immunotherapy 05/2018